WO1996033773A2 - Improvements in or relating to cosmetic treatment of skin lines - Google Patents
Improvements in or relating to cosmetic treatment of skin lines Download PDFInfo
- Publication number
- WO1996033773A2 WO1996033773A2 PCT/GB1996/001003 GB9601003W WO9633773A2 WO 1996033773 A2 WO1996033773 A2 WO 1996033773A2 GB 9601003 W GB9601003 W GB 9601003W WO 9633773 A2 WO9633773 A2 WO 9633773A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- skin
- cosmetic treatment
- treated
- light
- minutes
- Prior art date
Links
- 238000011282 treatment Methods 0.000 title claims abstract description 39
- 239000002537 cosmetic Substances 0.000 title claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 14
- 102000008186 Collagen Human genes 0.000 claims abstract description 6
- 108010035532 Collagen Proteins 0.000 claims abstract description 6
- 229920001436 collagen Polymers 0.000 claims abstract description 6
- 235000013305 food Nutrition 0.000 claims abstract description 6
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 230000001815 facial effect Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 238000005266 casting Methods 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 description 1
- 206010040925 Skin striae Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000031439 Striae Distensae Diseases 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000005441 aurora Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000008921 facial expression Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0616—Skin treatment other than tanning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/203—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser applying laser energy to the outside of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00452—Skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00452—Skin
- A61B2018/0047—Upper parts of the skin, e.g. skin peeling or treatment of wrinkles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
- A61N2005/0663—Coloured light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/062—Photodynamic therapy, i.e. excitation of an agent
Definitions
- the present invention relates to cosmetic treatment of skin lines.
- Lines appear on the skin as one ages and many regard them as undesirable, particularly those line that appear on the face and neck.
- Significant sums of money are spent annually on beauty products such as creams or ointments aimed at reducing such lines or at least slowing their progress.
- a method of cosmetic treatment of skin lines comprising the steps of exposing an area to be treated to orange light of wavelength in the range 585-560 nano metres and frequency 460-510 x 10 ⁇ : hertz for a period in the range 15 to 25 minutes, followed by yellow light of wavelength 575-585 nano metres and frequency 510-520x10 ' hertz for a period in the range 4 to 6 minutes.
- the skin to be treated is initially covered with collagen skin food prior to light being directed thereat.
- the area to be treated is exposed to orange light for 20 minutes and the yellow light for 5 minutes.
- the light source is positioned at a distance of 15 centimetres from the area to be treated.
- Figure 1 shows a plan view of a cast taken from skin around the left eye of a first subject before treatment as described in Example 1 :
- Figure 2 shows a plan view of a cast taken from the skin around the left eye of a first subject after a first treatment according to the present invention, as described in Example 1 :
- Figure 3 shows a plan view of a cast taken from the skin around the left eye of a first subject after a second treatment according to the present invention, as described in Example
- Figure 4 shows sectioned end views of casts taken from skin around the right eye of a first subject before treatment and after first and second treatments according to the present invention, as described in Example 1 ;
- Figure 5 shows perspective end views of the casts of figure 4.
- Figures 6 to 8 shows plan views of casts taken from skin area around the left eye of a second subject before treatment and after first and second treatments according to the present invention, as described in Example 2:
- Figure 9 shows an end view of a section through the casts of figures 6 and 8:
- Figure 10 shows a perspective end view of the casts of figure 9:
- Figures 1 1 to 13 show plan views of casts taken from skin around the left eye of a third subject as described in Example 3.
- the cosmetic treatment of the present application uses the known technique of chromotherapy whereby skin is exposed to controlled quantities of coloured light obtained by filtering the output of electric lamps.
- the machine used to produce the light is an Aurora 200SLR unit which has two articulated arms with end pods. Each pod contains a halogen lamp rated at 50 Watts. 24 Volts and an associated condenser lens. In front of the lens is a filter holder into which may be placed spectrally selective colour filters.
- the machine In order to treat fine skin lines such as those found on the face and neck the machine is used to direct light at the skin in a specific sequence of colours and with specific timing as described below.
- the skin food is of a known composition and comprises the following ingredients: purified water: soya oil: tsopropylmyristate: stearic acid: glycerine: jojoba oil: triethanolamine: collagen: octyl dimethyl PABA: synthetic beeswax: cetyl alcohol: diemethicone: carbomer: phenoxy ethanol butyl paraben: fragrance and colouring.
- the orange filters are placed into the lamp pods so that when the lamps are switched on orange light of wavelength 585-560 nano metres and frequency 460 x 10 * hertz is produced.
- the lamps are positioned at a distance of 6 inches ( 15 centimetres) from the area to be treated.
- the machine is then switched on and the light intensity is set to maximum.
- the treatment area is subjected to the orange light for a period of 20 minutes. Thereafter the filters are removed using a clean cloth to prevent fingerprint contamination (which may reduce the effectiveness of the treatment) and vellow filters are installed.
- the yellow filters provide yellow light of wavelength 575-585 nano metres and frequency 510 x l ⁇ ' ⁇ hertz and this is directed at the treatment area for a period of 5 minutes at maximum intensity.
- the light machine is then switched off and removed.
- the patient remains in position for five minutes to relax.
- the method described above may be applied to other marking of the skin such as stretch marks.
- a first subject being a male aged 45 was treated by taking a first cast from the skin area around the left and right eyes.
- the cast impression of around the left eye is shown in plan in figure 1.
- the cast around the right eye was sliced to enable the mould profile to be inspected and the result is shown in the top cast section of the photograph shown in figure 2.
- the significant creases represented by peaks in the cast section are marked with the letters A to F.
- a scale with 1mm divisions is shown at the bottom of the photograph.
- the top cast section in the photograph of figure 3 shows an angled view of the same cast with the peaks labelled in the same manner as in figure 2.
- the area of skin around the left and right eyes of the first subject was then exposed to orange light of wavelength 585-650 nano metres for a period of twenty minutes followed by exposure to yellow light of wavelength 575-585 nano metres for a period of six minutes.
- Figures 9 and 10 show sections through the casts before treatment (top) and after the second treatment (bottom). Again a 1mm scale is shown at the bottom of figure 9 and the middle of figure 10. Selected main elevations in the cast (representing lines in the skin) before treatment have been identified with the letters A to H. It will be seen that after treatment (bottom cast in each figure) only elevation F remains prominent at the cross- section. Elevations A. B. D. E. G and H are significantly diminished whereas C (perhaps the largest elevation before treatment) has disappeared completely. Again it will be apparent from figures 8 and 10 that the general surface texture of the skin is significantly smoother.
- Figures 1 1 to 13 show, respectively, castings taken from around the left eye of a third subject: a female aged 60. It will be seen that the number, height and length of each elevation has been reduced dramatically leaving only few elevations that are just visible without magnification.
Landscapes
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Radiology & Medical Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Radiation-Therapy Devices (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU54059/96A AU5405996A (en) | 1995-04-26 | 1996-04-26 | Improvements in or relating to cosmetic treatment of skin li nes |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9508499.2A GB9508499D0 (en) | 1995-04-26 | 1995-04-26 | Improvements in or relating to cosmetic treatment of skin lines |
GB9508499.2 | 1995-04-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1996033773A2 true WO1996033773A2 (en) | 1996-10-31 |
WO1996033773A3 WO1996033773A3 (en) | 1996-12-27 |
Family
ID=10773570
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1996/001003 WO1996033773A2 (en) | 1995-04-26 | 1996-04-26 | Improvements in or relating to cosmetic treatment of skin lines |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU5405996A (en) |
GB (1) | GB9508499D0 (en) |
WO (1) | WO1996033773A2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998008568A1 (en) * | 1996-08-29 | 1998-03-05 | Sls Biophile Limited | Wrinkle removal |
GB2336545A (en) * | 1998-04-21 | 1999-10-27 | Oe Lys Limited | Skin treatment |
GB2368020A (en) * | 2000-10-18 | 2002-04-24 | Icn Photonics Ltd | Treatment of acne vulgaris skin condition by irradiation with light of specific wavelengths to target specific chromophores & stimulate collagen production |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0026239A1 (en) * | 1979-09-29 | 1981-04-08 | Detlef Köppen | Medical and cosmetic irradiation apparatus |
FR2582523A1 (en) * | 1985-05-31 | 1986-12-05 | Cancoin Isabelle | Chromo-lumino-thermal device for cosmetic and relaxation treatment |
US5259380A (en) * | 1987-11-04 | 1993-11-09 | Amcor Electronics, Ltd. | Light therapy system |
DE4207523A1 (en) * | 1991-04-11 | 1992-10-15 | Schmid Christian | METHOD FOR GENERATING A LIGHT FOR COLOR THERAPY |
DE4127564A1 (en) * | 1991-08-21 | 1993-04-08 | Peter Hennig | Coloured light processor to give full colour spectrum from IR to UV light - has monochromatic colour filter with wavelength shift from 350 nm to 75 nm and output light can be conducted across glass fibre optic and can transmit cold light |
-
1995
- 1995-04-26 GB GBGB9508499.2A patent/GB9508499D0/en active Pending
-
1996
- 1996-04-26 AU AU54059/96A patent/AU5405996A/en not_active Abandoned
- 1996-04-26 WO PCT/GB1996/001003 patent/WO1996033773A2/en active Application Filing
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998008568A1 (en) * | 1996-08-29 | 1998-03-05 | Sls Biophile Limited | Wrinkle removal |
GB2336545A (en) * | 1998-04-21 | 1999-10-27 | Oe Lys Limited | Skin treatment |
GB2368020A (en) * | 2000-10-18 | 2002-04-24 | Icn Photonics Ltd | Treatment of acne vulgaris skin condition by irradiation with light of specific wavelengths to target specific chromophores & stimulate collagen production |
WO2002032505A1 (en) * | 2000-10-18 | 2002-04-25 | Icn Photonics Limited | Illumination radiation treatment of skin conditions |
Also Published As
Publication number | Publication date |
---|---|
AU5405996A (en) | 1996-11-18 |
GB9508499D0 (en) | 1995-06-14 |
WO1996033773A3 (en) | 1996-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zackheim | Origin of the human basal cell epithelioma | |
Fulton Jr | Utilizing the ultraviolet (UV detect) camera to enhance the appearance of photodamage and other skin conditions | |
US5860433A (en) | Eyebrow forming template and method | |
AU561477B2 (en) | Cosmetic products based on quaternary chitosan derivatives, new quaternary chitosan derivatives, and production process thereof | |
JP2001515545A (en) | Segment face mask | |
ATE144131T1 (en) | METHOD FOR PRODUCING COSMETIC HAIR CARE PRODUCTS AND THE COMPOSITION AND METHOD FOR THE COSMETIC USE OF THIS COMPOSITION | |
DE69202019D1 (en) | Use of essential fatty acids in the manufacture of a medicament for the treatment of AIDS. | |
Guyuron et al. | The nasolabial fold: a challenge, a solution | |
WO1996033773A2 (en) | Improvements in or relating to cosmetic treatment of skin lines | |
Tsukahara et al. | Determination of age‐related changes in the morphological structure (sagging) of the human cheek using a photonumeric scale and three‐dimensional surface parameters | |
Ziegler | Multicolor tattooing of the cornea | |
Chiramana et al. | A time saving method to fabricate a custom ocular prosthesis | |
Khan et al. | Conference report: materials research in maxillofacial prosthetics. | |
WO2021137562A1 (en) | Leather processing method and leather product manufactured thereby | |
CN108403504A (en) | A kind of hair scalp care essence breast containing chlorophyll and qinghaosu | |
JP2708692B2 (en) | Whitening cosmetics | |
Denny | Expanded midline forehead flap for coverage of nonnasal facial defects | |
Quaba | Results of argon laser treatment of port-wine stains: a method of assessment | |
Kromann et al. | The tattooings of the Qilakitsoq Eskimo mummies | |
DE69005113D1 (en) | USE OF PEROXID LIPIDS FOR PRODUCING A MEDICINAL PRODUCT FOR TREATING CIRCULAR INSUFFICIENCY IN LOCAL APPLICATION. | |
US2065316A (en) | Process of making reproductions | |
JP4761594B2 (en) | How to choose cosmetics | |
RU2122871C1 (en) | Method of rejuvenascence of face and neck skin | |
Wood et al. | Combined physical and computer-aided facial reconstruction in human skeletal remains | |
CN2601638Y (en) | Face stereo-plastic calibrator |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
122 | Ep: pct application non-entry in european phase |